Premium
AlloVir Inc (ALVR)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting fi... AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0099 | -1.90019193858 | 0.521 | 0.55 | 0.4758 | 310206 | 0.50578855 | CS |
| 4 | -0.1989 | -28.014084507 | 0.71 | 0.72 | 0.4758 | 374887 | 0.54388154 | CS |
| 12 | -0.2539 | -33.1895424837 | 0.765 | 1.05 | 0.4758 | 340159 | 0.72171411 | CS |
| 26 | -0.233 | -31.3129955651 | 0.7441 | 1.05 | 0.4758 | 318568 | 0.73352346 | CS |
| 52 | -1.8289 | -78.1581196581 | 2.34 | 2.485 | 0.4758 | 781948 | 0.77999181 | CS |
| 156 | -18.1089 | -97.2551020408 | 18.62 | 19.08 | 0.4758 | 696431 | 3.46603098 | CS |
| 260 | -0.0551 | -9.73154362416 | 0.5662 | 48.96 | 0.4758 | 564795 | 7.34829983 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
